Giampaolo Talamo
Overview
Explore the profile of Giampaolo Talamo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
699
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Talamo G, Oyeleye O, Paudel A, Tayyab H, Khan M, Meseeha M, et al.
Hematology
. 2025 Feb;
30(1):2458358.
PMID: 39918288
Background: Iron deficiency anemia (IDA) is the most common cause of anemia worldwide. Patients with IDA often present thrombocytosis, but little is known about its degree and prevalence, and its...
2.
Peralta L, Khan M, Meseeha M, Richards J, Poulose J, Talamo G
Hematology
. 2024 Nov;
29(1):2431405.
PMID: 39602205
Background: Hairy cell leukemia (HCL) is rare leukemia of mature B cells, accounting for 2% of all lymphoid neoplasms. Although the association of venous thromboembolism (VTE) with cancer is well...
3.
Im D, Alsheimer K, Poulose J, Zeykan V, Talamo G
Case Rep Oncol
. 2023 Nov;
16(1):1306-1310.
PMID: 37942403
Introduction: Tumor lysis syndrome (TLS) is an oncologic emergency characterized by several metabolic derangements, such as hyperuricemia, hyperkalemia, hyperphosphatemia, and hypocalcemia. TLS is typically observed in hematologic malignancies, especially after...
4.
Siegel D, Schiller G, Samaras C, Sebag M, Berdeja J, Ganguly S, et al.
Leukemia
. 2020 May;
34(12):3286-3297.
PMID: 32376855
Patients with multiple myeloma who have relapsed after or become refractory to lenalidomide in early treatment lines represent a clinically important population in need of effective therapies. The safety and...
5.
Siegel D, Schiller G, Song K, Agajanian R, Stockerl-Goldstein K, Kaya H, et al.
Br J Haematol
. 2019 Oct;
188(4):501-510.
PMID: 31588567
Patients with relapsed/refractory multiple myeloma (RRMM) for whom the benefits of lenalidomide have been exhausted in early treatment lines need effective therapies. In cohort A of the phase 2 MM-014...
6.
Smyth J, Johnson J, Auer B, Lehman E, Talamo G, Sciamanna C
JMIR Ment Health
. 2018 Dec;
5(4):e11290.
PMID: 30530460
Background: Positive affect journaling (PAJ), an emotion-focused self-regulation intervention, has been associated with positive outcomes among medical populations. It may be adapted for Web-based dissemination to address a need for...
7.
Francis E, Chen F, Kidacki M, Miller R, Alkhasoneh M, Talamo G, et al.
Clin Chim Acta
. 2018 Oct;
487:306-308.
PMID: 30315756
Background: Pseudohyperphosphatemia is a rare laboratory finding in MM, especially in patients with smoldering myeloma (SMM) progressing to symptomatic multiple myeloma (MM). Laboratorians and clinicians should be aware of this...
8.
Patel U, Drabick J, Malysz J, Talamo G
Clin Lymphoma Myeloma Leuk
. 2018 Sep;
18(12):e515-e519.
PMID: 30201257
Background: Multiple myeloma (MM) is characterized by the secretion of monoclonal protein by malignant plasma cells in the vast majority of cases. We identified and analyzed patterns of disease relapse...
9.
Koller K, Mackley H, Liu J, Wagner H, Talamo G, Schell T, et al.
Cancer Biol Ther
. 2016 Dec;
18(1):36-42.
PMID: 27905824
There is a growing body of evidence supporting the synergistic roles of radiotherapy and immunotherapy in the treatment of malignancy. Published case studies of the abscopal effect have been reported...
10.
Al-Marrawi M, Mackley H, Ali S, Wagner H, Joshi M, Holder S, et al.
Clin Genitourin Cancer
. 2016 Feb;
14(4):e393-9.
PMID: 26877063
No abstract available.